Patients should be carefully monitored, and the risks weighed against the benefits on a case-by-case basis, particularly when used outside of its original medical context
H., & Ludwig, D
if not, it may request additional info or eventually send an approval/denial
These two routes of action do not appear to compete, and animal data do not suggest additive toxicity
However, the effects of PARP-1 on LXR-mediated ABCA1 expression and cholesterol efflux from -cells remain unknown
Additionally, new or worsening constipation accompanied by unexplained weight loss (beyond expected therapeutic weight reduction), persistent changes in stool caliber, or alternating constipation and diarrhea warrants evaluation to exclude structural or neoplastic causes, particularly in patients age 45 or older or those with family history of colorectal cancer